Breaking News Instant updates and real-time market news.

YELP

Yelp

$26.70 /

+0.07 (+0.26%)

16:14
08/06/20
08/06
16:14
08/06/20
16:14

Yelp reports Q2 EPS (33c), consensus (51c)

Reports Q2 revenue $169M, consensus $153.46M. "Our second quarter results demonstrate the resilience of our business, in spite of the significant headwinds faced by local economies following the emergence of COVID-19," said Jeremy Stoppelman, Yelp's co-founder and chief executive officer. "Due to our disciplined actions on expenses, coupled with solid revenue performance, we added $35M of cash and cash equivalents to our balance sheet. Though the pace of economic recovery remains uncertain and will not be uniform, we have confidence in our ability to execute in this environment and in the strength of our diversified business."

  • 06

    Aug

  • 07

    Aug

YELP Yelp
$26.70 /

+0.07 (+0.26%)

06/10/20 BTIG
Yelp initiated with a Neutral at BTIG
06/10/20 Citi
Yelp price target raised to $26 from $21 at Citi
05/11/20
Fly Intel: Top five analyst downgrades
05/11/20 BMO Capital
Yelp downgraded to Market Perform from Outperform at BMO Capital

TODAY'S FREE FLY STORIES

Conference/Events
BofA internet & auto analysts to hold an analyst/industry conference call » 11:19
10/01/20
10/01
11:19
10/01/20
11:19
CVNA

Carvana

$238.06 /

+14.34 (+6.41%)

, VRM

Vroom

$51.11 /

-0.91 (-1.75%)

, KMX

CarMax

$92.78 /

+0.87 (+0.95%)

, LAD

Lithia Motors

$244.26 /

+16.1 (+7.06%)

, AN

AutoNation

$53.60 /

+0.67 (+1.27%)

Internet/e-Commerce…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CVNA Carvana
$238.06 /

+14.34 (+6.41%)

VRM Vroom
$51.11 /

-0.91 (-1.75%)

KMX CarMax
$92.78 /

+0.87 (+0.95%)

LAD Lithia Motors
$244.26 /

+16.1 (+7.06%)

AN AutoNation
$53.60 /

+0.67 (+1.27%)

CVNA Carvana
$238.06 /

+14.34 (+6.41%)

09/29/20 Piper Sandler
Carvana price target raised to $265 from $209 at Piper Sandler
09/23/20 Needham
Carvana price target raised to $265 from $200 at Needham
09/23/20 B. Riley FBR
Carvana downgraded to Neutral on valuation at B. Riley FBR
09/23/20 B. Riley FBR
Carvana downgraded to Neutral from Buy at B. Riley FBR
VRM Vroom
$51.11 /

-0.91 (-1.75%)

09/23/20 JMP Securities
Vroom price target raised to $75 from $66 at JMP Securities
09/22/20 JPMorgan
JPMorgan ups Carvana to Overweight after 'surprise' profitability acceleration
09/22/20 Goldman Sachs
Vroom upgraded to Buy from Neutral at Goldman Sachs
09/09/20
Fly Intel: Top five analyst upgrades
KMX CarMax
$92.78 /

+0.87 (+0.95%)

09/25/20 Stephens
CarMax should be bought on post-earnings pullback, says Stephens
09/25/20 Baird
CarMax price target raised to $110 from $100 at Baird
09/22/20 RBC Capital
CarMax price target raised to $110 from $100 at RBC Capital
08/18/20 Wedbush
CarMax price target raised to $120 from $100 at Wedbush
LAD Lithia Motors
$244.26 /

+16.1 (+7.06%)

08:41 Today Craig-Hallum
Lithia Motors price target raised to $300 from $260 at Craig-Hallum
08/28/20 JPMorgan
Lithia Motors price target raised to $280 from $240 at JPMorgan
08/27/20 Benchmark
Benchmark sees more strong earnings from auto dealers, ups targets in group
08/12/20 Guggenheim
Lithia Motors price target raised to $275 from $233 at Guggenheim
AN AutoNation
$53.60 /

+0.67 (+1.27%)

08/28/20 JPMorgan
Lithia Motors price target raised to $280 from $240 at JPMorgan
08/12/20
Fly Intel: Top five analyst upgrades
08/12/20 Guggenheim
Guggenheim 'increasingly bullish' on AutoNation after earnings, upgrades to Buy
08/12/20 Guggenheim
AutoNation upgraded to Buy from Neutral at Guggenheim
CVNA Carvana
$238.06 /

+14.34 (+6.41%)

VRM Vroom
$51.11 /

-0.91 (-1.75%)

KMX CarMax
$92.78 /

+0.87 (+0.95%)

LAD Lithia Motors
$244.26 /

+16.1 (+7.06%)

AN AutoNation
$53.60 /

+0.67 (+1.27%)

  • 01
    Oct
  • 11
    Sep
  • 09
    Jun
  • 19
    May
CVNA Carvana
$238.06 /

+14.34 (+6.41%)

KMX CarMax
$92.78 /

+0.87 (+0.95%)

AN AutoNation
$53.60 /

+0.67 (+1.27%)

CVNA Carvana
$238.06 /

+14.34 (+6.41%)

VRM Vroom
$51.11 /

-0.91 (-1.75%)

KMX CarMax
$92.78 /

+0.87 (+0.95%)

LAD Lithia Motors
$244.26 /

+16.1 (+7.06%)

AN AutoNation
$53.60 /

+0.67 (+1.27%)

CVNA Carvana
$238.06 /

+14.34 (+6.41%)

VRM Vroom
$51.11 /

-0.91 (-1.75%)

KMX CarMax
$92.78 /

+0.87 (+0.95%)

AN AutoNation
$53.60 /

+0.67 (+1.27%)

Technical Analysis
NASDAQ market internals summary » 11:17
10/01/20
10/01
11:17
10/01/20
11:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
$0.00 /

+ (+0.00%)

Technical Analysis
NYSE market internals summary » 11:16
10/01/20
10/01
11:16
10/01/20
11:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
$0.00 /

+ (+0.00%)

Hot Stocks
Exxon Mobil names Craig Morford to succeed Randall Ebner as general counsel » 11:15
10/01/20
10/01
11:15
10/01/20
11:15
XOM

Exxon Mobil

$33.23 /

-1.105 (-3.22%)

Randall Ebner, vice…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XOM Exxon Mobil
$33.23 /

-1.105 (-3.22%)

XOM Exxon Mobil
$33.23 /

-1.105 (-3.22%)

09/23/20 Scotiabank
Exxon Mobil upgraded to Sector Perform from Underperform at Scotiabank
09/11/20 Standpoint Research
Exxon Mobil upgraded to Buy from Hold at Standpoint Research
09/10/20
Fly Intel: Top five analyst initiations
09/10/20 MKM Partners
Exxon Mobil initiated with a Buy at MKM Partners
XOM Exxon Mobil
$33.23 /

-1.105 (-3.22%)

XOM Exxon Mobil
$33.23 /

-1.105 (-3.22%)

XOM Exxon Mobil
$33.23 /

-1.105 (-3.22%)

XOM Exxon Mobil
$33.23 /

-1.105 (-3.22%)

General news
4-Week Bill Auction to be released at 11:30  11:15
10/01/20
10/01
11:15
10/01/20
11:15
 
General news
8-Week Bill Auction to be released at 11:30  11:15
10/01/20
10/01
11:15
10/01/20
11:15
 
Hot Stocks
General Motors delivered 665,192 vehicles in Q3, down 10% y/y » 11:14
10/01/20
10/01
11:14
10/01/20
11:14
GM

General Motors

$29.38 /

-0.21 (-0.71%)

General Motors announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GM General Motors
$29.38 /

-0.21 (-0.71%)

GM General Motors
$29.38 /

-0.21 (-0.71%)

09/22/20 Morgan Stanley
Morgan Stanley says 'Battery Day' may be more significant to industry than Tesla
09/17/20 Roth Capital
Roth raises Workhorse target to $33 after Lordstown's 'compelling' analyst day
09/17/20 Deutsche Bank
GM news 'potentially disruptive' to powertrain suppliers, says Deutsche Bank
09/14/20 JPMorgan
Core criticism of Nikola short report 'misconceived,' says JPMorgan
GM General Motors
$29.38 /

-0.21 (-0.71%)

GM General Motors
$29.38 /

-0.21 (-0.71%)

GM General Motors
$29.38 /

-0.21 (-0.71%)

GM General Motors
$29.38 /

-0.21 (-0.71%)

General news
52-Week Bill Announcement CUSIP Number data reported » 11:14
10/01/20
10/01
11:14
10/01/20
11:14

52-Week Bill Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
52-Week Bill Announcement Offering Amount data reported » 11:13
10/01/20
10/01
11:13
10/01/20
11:13

52-Week Bill Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
3-Yr Note Announcement CUSIP Number data reported » 11:13
10/01/20
10/01
11:13
10/01/20
11:13

3-Yr Note Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
3-Yr Note Announcement Offering Amount data reported » 11:13
10/01/20
10/01
11:13
10/01/20
11:13

3-Yr Note Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
30-Yr Bond Announcement CUSIP Number data reported » 11:13
10/01/20
10/01
11:13
10/01/20
11:13

30-Yr Bond Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
30-Yr Bond Announcement Offering Amount data reported » 11:13
10/01/20
10/01
11:13
10/01/20
11:13

30-Yr Bond Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
10-Yr Note Announcement CUSIP Number data reported » 11:13
10/01/20
10/01
11:13
10/01/20
11:13

10-Yr Note Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
10-Yr Note Announcement Offering Amount data reported » 11:13
10/01/20
10/01
11:13
10/01/20
11:13

10-Yr Note Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
6-Month Bill Announcement Offering Amount data reported » 11:13
10/01/20
10/01
11:13
10/01/20
11:13

6-Month Bill Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
3-Month Bill Announcement Offering Amount data reported » 11:13
10/01/20
10/01
11:13
10/01/20
11:13

3-Month Bill Announcement…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
CareDx entrenched deeper into transplants with Palmetto LCD, says Piper » 11:07
10/01/20
10/01
11:07
10/01/20
11:07
CDNA

CareDx

$41.38 /

+3.35 (+8.81%)

Palmetto issued a final…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDNA CareDx
$41.38 /

+3.35 (+8.81%)

CDNA CareDx
$41.38 /

+3.35 (+8.81%)

08:26 Today Craig-Hallum
CareDx may receive HeartCare Medicare reimbursement, says Craig-Hallum
08/06/20 BTIG
CareDx price target raised to $45 from $40 at BTIG
08/05/20 H.C. Wainwright
CareDx price target raised to $40 from $37 at H.C. Wainwright
06/29/20 Piper Sandler
CareDx a top pick in diagnostics at Piper Sandler
CDNA CareDx
$41.38 /

+3.35 (+8.81%)

  • 11
    Jun
Options
Rocket Companies call volume above normal and directionally bullish » 11:05
10/01/20
10/01
11:05
10/01/20
11:05
RKT

Rocket Companies

$21.24 /

+1.315 (+6.60%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

09/25/20 Susquehanna
Rocket Companies upgraded to Neutral on valuation at Susquehanna
09/25/20 Susquehanna
Rocket Companies upgraded to Neutral from Negative at Susquehanna
09/10/20 Wedbush
Rocket Companies initiated with a Neutral, $24 price target at Wedbush
09/09/20 Wedbush
Rocket Companies initiated with a Neutral at Wedbush
RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

  • 06
    Aug
RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

RKT Rocket Companies
$21.24 /

+1.315 (+6.60%)

Periodicals
Celsius Holdings sinks following short report from 'The Bear Cave" » 11:02
10/01/20
10/01
11:02
10/01/20
11:02
CELH

Celsius Holdings

$23.91 /

+1.16 (+5.10%)

Shares of Celsius…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CELH Celsius Holdings
$23.91 /

+1.16 (+5.10%)

CELH Celsius Holdings
$23.91 /

+1.16 (+5.10%)

08/07/20 Ladenburg
Celsius Holdings price target raised to $23.50 from $11.75 at Ladenburg
08/06/20 Roth Capital
Celsius Holdings price target raised to $25 from $14.50 at Roth Capital
07/28/20 B. Riley FBR
Celsius Holdings price target raised to $17 from $11.50 at B. Riley FBR
06/24/20 Maxim
Celsius Holdings price target raised to $15 from $12 at Maxim
CELH Celsius Holdings
$23.91 /

+1.16 (+5.10%)

Recommendations
Solaria price target raised to EUR 18 from EUR 11 at RBC Capital » 11:02
10/01/20
10/01
11:02
10/01/20
11:02
SEYMF

Solaria

$0.00 /

+ (+0.00%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
The U.S. construction spending report beat estimates » 11:00
10/01/20
10/01
11:00
10/01/20
11:00

The U.S. construction…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Recommendations
Chardan boosts Solid Biosciences target 250% to $12.50 from $5 » 10:55
10/01/20
10/01
10:55
10/01/20
10:55
SLDB

Solid Biosciences

$4.42 /

+2.39 (+117.73%)

Chardan analyst Gbola…

Chardan analyst Gbola Amusa raised the firm's price target on Solid Biosciences to $12.50 from $5 and keeps a Buy rating on the shares after the FDA lifted the clinical hold on the Phase I/II IGNITE DMD trial of AAV9-based gene therapy SGT-001 in Duchenne muscular dystrophy. Today's news is an "important positive" given that manufacturing constraints in the space leave an opportunity for Solid, and the view from many in the market that SGT-001 may not return to the clinic, Amusa tells investors in a research note. Duchenne muscular dystrophy is a "vast opportunity" for gene therapies, and one that could take Solid "significantly past" the new price target with progress, adds the analyst. The stock in morning trading is up 125% to $4.56.

ShowHide Related Items >><<
SLDB Solid Biosciences
$4.42 /

+2.39 (+117.73%)

SLDB Solid Biosciences
$4.42 /

+2.39 (+117.73%)

10:47 Today Chardan
Solid Biosciences price target raised to $12.50 from $5 at Chardan
07/28/20 SVB Leerink
Solid Biosciences downgraded to Market Perform at SVB Leerink
07/28/20 SVB Leerink
Solid Biosciences downgraded to Market Perform from Outperform at SVB Leerink
05/08/20 Nomura Instinet
Solid Biosciences price target lowered to $6 from $10 at Nomura Instinet
Options
AbbVie put volume heavy and directionally bearish » 10:55
10/01/20
10/01
10:55
10/01/20
10:55
ABBV

AbbVie

$87.65 /

+0.13 (+0.15%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABBV AbbVie
$87.65 /

+0.13 (+0.15%)

ABBV AbbVie
$87.65 /

+0.13 (+0.15%)

09/29/20 Berenberg
AbbVie initiated with a Hold at Berenberg
09/28/20 Mizuho
Mizuho 'incrementally more bullish' on AbbVie integration of Allergan
09/02/20 Citi
AbbVie revenue potential offsets subpoena risk, says Citi
08/24/20 H.C. Wainwright
Galapagos downgraded to Neutral from Buy at H.C. Wainwright
ABBV AbbVie
$87.65 /

+0.13 (+0.15%)

ABBV AbbVie
$87.65 /

+0.13 (+0.15%)

ABBV AbbVie
$87.65 /

+0.13 (+0.15%)

Conference/Events
Federal Reserve Bank of New York to hold a virtual conference » 10:55
10/01/20
10/01
10:55
10/01/20
10:55
UBS

UBS

$11.17 /

+0.005 (+0.04%)

, GS

Goldman Sachs

$200.10 /

-1.01 (-0.50%)

2nd New York Fed Research…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UBS UBS
$11.17 /

+0.005 (+0.04%)

GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

UBS UBS
$11.17 /

+0.005 (+0.04%)

07/24/20 Morgan Stanley
UBS price target raised to CHF 12 from CHF 11 at Morgan Stanley
07/23/20 Oddo BHF
UBS upgraded to Neutral from Reduce at Oddo BHF
07/22/20 Credit Suisse
UBS price target raised to CHF 14.50 from CHF 14 at Credit Suisse
07/22/20 RBC Capital
UBS price target raised to CHF 12 from CHF 11 at RBC Capital
GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

09/30/20 BofA
Goldman Sachs added to US 1 List, Citi removed at BofA
09/23/20 UBS
Goldman Sachs upgraded to Buy from Neutral at UBS
08/06/20 Piper Sandler
Now is the time to buy Goldman Sachs, says Piper Sandler
07/20/20 Berenberg
Goldman Sachs price target raised to $200 from $160 at Berenberg
UBS UBS
$11.17 /

+0.005 (+0.04%)

GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

UBS UBS
$11.17 /

+0.005 (+0.04%)

GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

UBS UBS
$11.17 /

+0.005 (+0.04%)

GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

GS Goldman Sachs
$200.10 /

-1.01 (-0.50%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.